Correction of breast deformities after breast-conserving surgery in Chinese women with breast cancer: a narrative review
Wu Z., Zhong L., Gu J., Xie H., Guo F.
Narrative Review, published in Front Oncol (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Oncol (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41049853
- PMCID
- PMC12488419
- DOI
- 10.3389/fonc.2025.1648679
Abstract (original English)
Breast-conserving therapy (BCT) is a key treatment option for early-stage breast cancer, balancing oncologic control with cosmetic outcomes. However, postoperative breast deformities occur in approximately 25% to 30% of cases, significantly impacting patients' body image and psychological well-being. Although advances in oncoplastic surgery have demonstrated the safety and efficacy of corrective procedures-effectively improving breast appearance, alleviating anxiety, and enhancing quality of life-the acceptance rate of such surgeries remains relatively low in China. This reluctance is influenced by multiple factors, including personal characteristics, social support, disease-related features, and treatment experiences. This article reviews the necessity and safety of deformity correction after BCT, as well as the factors affecting patients' willingness to undergo such procedures. The aim is to help clinicians identify suitable candidates for corrective surgery, promote multidisciplinary interventions and decision-making support, and ultimately improve the correction rate and overall quality of life for breast cancer patients.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.